CISH Antibody [J15C14]

N. catalogo F1277

Stampa

Descrizione biologica

Specificità CISH Antibody [J15C14] rileva i livelli endogeni della proteina CISH totale.
Contesto La proteina CISH (Cytokine-inducible SH2-containing protein), membro fondatore della famiglia Suppressor of Cytokine Signaling (SOCS), funge da regolatore intracellulare chiave della segnalazione delle citochine e dell'omeostasi immunitaria. CISH comprende una regione variabile N-terminale, un dominio SH2 (Src homology 2) centrale che lega i residui di fosfotirosina sui recettori delle citochine attivati e una scatola SOCS C-terminale che media il reclutamento del complesso elongina B/C, formando un complesso E3 ubiquitina ligasi che dirige le proteine associate al segnale per la degradazione proteasomica. Il dominio SH2 interagisce specificamente con le chinasi JAK fosforilate e le catene dei recettori delle citochine, come quelle attivate da IL-2, IL-3, IL-5 e IL-7, stabilendo un meccanismo di feedback che inibisce l'attivazione prolungata di JAK/STAT. CISH agisce come un checkpoint negativo nella segnalazione delle cellule immunitarie, in particolare modulando le soglie di attivazione delle cellule T regolatorie (Tregs), delle cellule natural killer (NK) e delle cellule T CD8+. Attraverso questa attività inibitoria, affina le risposte effettrici, mantenendo la tolleranza e prevenendo l'iperattivazione immunitaria durante la stimolazione antigenica cronica. Nella regolazione ematopoietica, CISH smorza l'attivazione di STAT5 guidata dall'eritropoietina (EPO), limitando così l'eccessiva proliferazione eritroide. L'espressione deregolata di CISH è stata correlata a un'immunità antitumorale compromessa, come nel linfoma splenico della zona marginale, mentre i polimorfismi genetici in CISH predispongono gli individui a malattie infettive come la tubercolosi e la malaria alterando la responsività alle citochine.

Informazioni sullutilizzo

Applicazione WB, IP, FCM Diluizione
WB IP FCM
1:1000 1:100 1:50 - 1:200
Reattività Human, Mouse
Fonte Rabbit Monoclonal Antibody MW 32 kDa, 37 kDa
Tampone di conservazione PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Conservazione
(Dalla data di ricevimento)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Riferimenti

  • https://pubmed.ncbi.nlm.nih.gov/37628937/
  • https://pubmed.ncbi.nlm.nih.gov/7796808/

Dati di applicazione

WB

Validato da Selleck

  • F1277-wb
    Lane 1: NK-92, Lane 2: NK-92 (hIL-2, 10 ng/ml, overnight), Lane 3: BaF3, Lane 4: BaF3 (mIL-3, 10 ng/ml, 6 h)